(Q34390355)

1 August 2017

1 reference

title

Recent developments in the management of haemophagocytic lymphohistiocytosis (English)

1 reference

1 August 2017

Imashuku S

1

1 reference

1 August 2017

Teramura T

series ordinal

2

1 reference

1 August 2017

Morimoto A

series ordinal

3

1 reference

1 August 2017

Hibi S

series ordinal

4

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Expert Opinion on Pharmacotherapy

1 August 2017

published in

1 reference

1 August 2017

volume

2

1 reference

1 August 2017

issue

9

1 reference

1 August 2017

page(s)

1437-1448

1 reference

Hemophagocytic syndrome (HPS) in children and adults

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

X-linked lymphoproliferative disease: twenty-five years after the discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Evolving strategies in the treatment of sepsis and systemic inflammatory response syndrome (SIRS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Biomarker and morphological characteristics of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Further evidence for genetic heterogeneity in familial hemophagocytic lymphohistiocytosis (FHLH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Induction of apoptosis and caspase activation in cells obtained from familial haemophagocytic lymphohistiocytosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Immunologic dysregulation in a patient with familial hemophagocytic lymphohistiocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Haemophagocytic lymphohistiocytosis, interferon-gamma-naemia and Epstein-Barr virus involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Liposteroid (dexamethasone palmitate) therapy for West syndrome: a comparative study with ACTH therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Hypertension after renal transplantation in patients treated with cyclosporin and azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

The mechanism of action of cyclosporin A and FK506.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Management of severe neutropenia with cyclosporin during initial treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Treatment of familial erythrophagocytic lymphohistiocytosis with cyclosporine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16-213.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Etoposide (VP-16) inhibits Epstein-Barr virus determined nuclear antigen (EBNA) synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Neuropathology of familial erythrophagocytic lymphohistiocytosis: six cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Familial hemophagocytic lymphohistiocytosis: improved neurodevelopmental outcome after bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

MRI in acute disseminated encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Acyclovir inhibition of Epstein-Barr virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Acyclovir for treatment of infectious mononucleosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Antithrombin III in patients with severe sepsis: a pharmacokinetic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Therapeutic rationale for antithrombin III in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

G-CSF enhanced granulocyte production in a child with severe neutropenia in the setting of fatal virus-associated hemophagocytic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Successful treatment of virus-associated haemophagocytic syndrome in adults by cyclosporin A supported by granulocyte colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.9.1437

10.1517/14656566.2.9.1437

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference